Iradimed Corporation (NASDAQ:IRMD) Short Interest Up 18.2% in December

Iradimed Corporation (NASDAQ:IRMD) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 124,100 shares, an increase of 18.2% from the December 15th total of 105,000 shares. Approximately 1.6% of the company’s shares are short sold. Based on an average daily volume of 39,400 shares, the short-interest ratio is currently 3.1 days.

Insider Transactions at Iradimed

In other Iradimed news, CFO John Glenn sold 2,500 shares of the firm’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $54.18, for a total value of $135,450.00. Following the completion of the sale, the chief financial officer now directly owns 4,383 shares in the company, valued at $237,470.94. This trade represents a 36.32 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 37.10% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Iradimed

Several large investors have recently made changes to their positions in IRMD. Charles Schwab Investment Management Inc. lifted its holdings in shares of Iradimed by 189.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 66,632 shares of the medical equipment provider’s stock valued at $3,351,000 after purchasing an additional 43,635 shares during the last quarter. Oak Ridge Investments LLC purchased a new position in shares of Iradimed during the third quarter valued at approximately $2,188,000. Eagle Asset Management Inc. purchased a new position in shares of Iradimed during the third quarter valued at approximately $1,239,000. Albert D Mason Inc. purchased a new position in shares of Iradimed during the third quarter valued at approximately $737,000. Finally, Barclays PLC lifted its holdings in shares of Iradimed by 113.9% during the third quarter. Barclays PLC now owns 23,774 shares of the medical equipment provider’s stock valued at $1,196,000 after purchasing an additional 12,657 shares during the last quarter. 92.34% of the stock is currently owned by hedge funds and other institutional investors.

Iradimed Price Performance

IRMD traded up $0.81 on Friday, hitting $59.17. The company had a trading volume of 50,168 shares, compared to its average volume of 37,022. Iradimed has a 52-week low of $40.18 and a 52-week high of $59.31. The stock has a fifty day simple moving average of $54.76 and a 200-day simple moving average of $50.17. The firm has a market capitalization of $749.68 million, a P/E ratio of 40.53 and a beta of 0.81.

Iradimed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Friday, November 15th were issued a $0.15 dividend. The ex-dividend date was Friday, November 15th. This represents a $0.60 annualized dividend and a yield of 1.01%. Iradimed’s dividend payout ratio (DPR) is presently 41.10%.

About Iradimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.